Sunil Shah

o2h Ventures is an established fund manager based in the heart of the biotech community in central Cambridge. We are a specialist fund that only invests in biotech therapeutics and the intersection between biotechnology and AI/ML. This fund is pivotal in developing the biotech ecosystem in the o2h Group but also has invested into 28 early-stage biotech companies in Great Britain. We have two specialist tax-efficient funds open for investment - 1. The o2h human health SEIS Fund 2. The o2h human health EIS knowledge-intensive Fund Disclaimer: Please refer to the relevant fund’s full risk warnings contained in their Information Memorandums. Your capital is at risk. Investing in early-stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. o2h Ventures’ funds are targeted exclusively at sophisticated or high-net-worth investors who understand these risks and make their own investment decisions. Tax relief depends on an individual’s circumstances and may change in the future. In addition, the availability of tax relief depends on the company invested in maintaining its qualifying status. Past performance is not a reliable indicator of future performance. You should not rely on any past performance as a guarantee of future investment performance. o2h Ventures Ltd is a limited company registered in England and Wales under number 11397838 and is authorised and regulated by the Financial Conduct Authority (FRN 812245). The registered office and principal place of business is Hauxton House, Mill Scitech Park, Mill Lane, Hauxton, Cambridge, CB22 5HX, United Kingdom.